These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 15466280

  • 1. Plasma protein aspartyl damage is increased in hemodialysis patients: studies on causes and consequences.
    Perna AF, Ingrosso D, Satta E, Lombardi C, Galletti P, D'Aniello A, De Santo NG.
    J Am Soc Nephrol; 2004 Oct; 15(10):2747-54. PubMed ID: 15466280
    [Abstract] [Full Text] [Related]

  • 2. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients--Italian initiative on uremic hyperhomocysteinemia (IIUH).
    Perna AF, Ingrosso D, Molino D, Galletti P, Montini G, Zacchello G, Bellantuono R, Caringella A, Fede C, Chimenz R, De Santo NG.
    J Nephrol; 2003 Oct; 16(4):516-21. PubMed ID: 14696753
    [Abstract] [Full Text] [Related]

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 4. Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.
    Tsubakihara Y, Takabatake Y, Oka K, Shoji T, Togawa M, Okada N, Takahito I, Imai E.
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S38-41. PubMed ID: 12612950
    [Abstract] [Full Text] [Related]

  • 5. Adverse effects of hyperhomocysteinemia and their management by folic acid.
    Perna AF, De Santo NG, Ingrosso D.
    Miner Electrolyte Metab; 1997 Mar; 23(3-6):174-8. PubMed ID: 9387111
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of toxic metals in blood and urine samples of chronic renal failure patients, before and after dialysis.
    Kazi TG, Jalbani N, Kazi N, Jamali MK, Arain MB, Afridi HI, Kandhro A, Pirzado Z.
    Ren Fail; 2008 Mar; 30(7):737-45. PubMed ID: 18704823
    [Abstract] [Full Text] [Related]

  • 7. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V, Kes P, Zeljko R, Kusec V.
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [Abstract] [Full Text] [Related]

  • 8. Plasma proteins containing damaged L-isoaspartyl residues are increased in uremia: implications for mechanism.
    Perna AF, Castaldo P, De Santo NG, di Carlo E, Cimmino A, Galletti P, Zappia V, Ingrosso D.
    Kidney Int; 2001 Jun; 59(6):2299-308. PubMed ID: 11380834
    [Abstract] [Full Text] [Related]

  • 9. Changes in plasma concentrations of hypoxanthine and uric acid before and after hemodialysis.
    Shahbazian H, Zand Moghadam A, Ehsanpour A, Khazaali M.
    Iran J Kidney Dis; 2009 Jul; 3(3):151-5. PubMed ID: 19617664
    [Abstract] [Full Text] [Related]

  • 10. The effect of mesna on plasma total homocysteine concentration in hemodialysis patients.
    Urquhart BL, Freeman DJ, Spence JD, House AA.
    Am J Kidney Dis; 2007 Jan; 49(1):109-17. PubMed ID: 17185151
    [Abstract] [Full Text] [Related]

  • 11. [On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane].
    Sirolli V, Cappelli P, Amoroso L, Di Liberato L, Muscianese P, Santarelli P, Del Rosso G, Bonomini M.
    G Ital Nefrol; 2004 Jan; 21 Suppl 30():S208-11. PubMed ID: 15750987
    [Abstract] [Full Text] [Related]

  • 12. Toxic effects of hyperhomocysteinemia in chronic renal failure and in uremia: cardiovascular and metabolic consequences.
    Perna AF, Capasso R, Acanfora F, Satta E, Lombardi C, Ingrosso D, Violetti E, Romano MM, De Santo NG.
    Semin Nephrol; 2006 Jan; 26(1):20-3. PubMed ID: 16412820
    [Abstract] [Full Text] [Related]

  • 13. [Study of the binding characteristics of chlorophenoxyisobutyric acid to serum proteins in chronically uremic patients : influence of dialysis and heparine (author's transl)].
    Lacour B, Di Giulio S, Nicolaï A, Drüeke T, Debray M, Boulu RG.
    Nephrologie; 1982 Jan; 3(1):19-22. PubMed ID: 7088259
    [Abstract] [Full Text] [Related]

  • 14. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M, Tazza L, Merki E, Giungi S, Luciani G, Miller ER, Lin EB, Tortorelli A, Tsimikas S.
    Blood Purif; 2007 Jan; 25(5-6):457-65. PubMed ID: 18075247
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM, Youssef AM, Zayoon MY.
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Does increasing blood pH stimulate protein synthesis in dialysis patients?
    Ruggieri F, Caso G, Wegmann M, McNurlan MA, Wahl C, Imoberdorf R, Garlick PJ, Ballmer PE.
    Nephron Clin Pract; 2009 Oct; 112(4):c276-83. PubMed ID: 19546588
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.